Loading insider details...
Beta
Latest Form 4 (Sep 4, 2026): Sale of 709 EDIT shares, $2.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Editas Medicine, Inc. (EDIT) | Sale | 709 | $2.2K |
| Jul 29, 2026 | Editas Medicine, Inc. (EDIT) | Sale | 4,928 | $13.2K |
| Jun 5, 2026 | Editas Medicine, Inc. (EDIT) | Sale | 731 | $2.0K |
| Mar 16, 2026 | Editas Medicine, Inc. (EDIT) | Grant/Award | 292,856 | n/a |
| Mar 4, 2026 | Editas Medicine, Inc. (EDIT) | Sale | 749 | $1.5K |
| Dec 4, 2025 | Editas Medicine, Inc. (EDIT) | Sale | 713 | $1.5K |
| Sep 4, 2025 | Editas Medicine, Inc. (EDIT) | Sale | 710 | $1.8K |
| Aug 4, 2025 | Editas Medicine, Inc. (EDIT) | Sale | 5,121 | $12.8K |
| Jun 4, 2025 | Editas Medicine, Inc. (EDIT) | Sale | 726 | $1.3K |
| Mar 27, 2025 | Editas Medicine, Inc. (EDIT) | Grant/Award | 275,100 | n/a |